# Gene Therapy for Painful Diabetic Neuropathy

> **NCT01002235** · PHASE1,PHASE2 · COMPLETED · sponsor: **Helixmith Co., Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Painful Diabetic Peripheral Neuropathy

## Interventions

- **BIOLOGICAL:** VM202

## Key facts

- **NCT ID:** NCT01002235
- **Lead sponsor:** Helixmith Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-04
- **Final completion:** 2012-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002235, "Gene Therapy for Painful Diabetic Neuropathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01002235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*